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Abstract
Background: Ciguatoxins (CTXs) are polyether marine neurotoxins and potent activators of voltage-gated sodium
channels. This toxin is carried by multiple reef-fish species and human consumption of ciguatoxins can result in an
explosive gastrointestinal/neurologic illness. This study characterizes the global transcriptional response in mouse
brain to a symptomatic dose of the highly toxic Pacific ciguatoxin P-CTX-1 and additionally compares this data to
transcriptional profiles from liver and whole blood examined previously. Adult male C57/BL6 mice were injected
with 0.26 ng/g P-CTX-1 while controls received only vehicle. Animals were sacrificed at 1, 4 and 24 hrs and
transcriptional profiling was performed on brain RNA with Agilent whole genome microarrays. RT-PCR was used to
independently validate gene expression and the web tool DAVID was used to analyze gene ontology (GO) and
molecular pathway enrichment of the gene expression data.
Results: A pronounced 4°C hypothermic response was recorded in these mice, reaching a minimum at 1 hr and
lasting for 8 hrs post toxin exposure. Ratio expression data were filtered by intensity, fold change and p-value, with
the resulting data used for time course analysis, K-means clustering, ontology classification and KEGG pathway
enrichment. Top GO hits for this gene set included acute phase response and mono-oxygenase activity. Molecular
pathway analysis showed enrichment for complement/coagulation cascades and metabolism of xenobiotics. Many
immediate early genes such as Fos, Jun and Early Growth Response isoforms were down-regulated although
others associated with stress such as glucocorticoid responsive genes were up-regulated. Real time PCR
confirmation was performed on 22 differentially expressed genes with a correlation of 0.9 (Spearman’s Rho,
p < 0.0001) with microarray results.
Conclusions: Many of the genes differentially expressed in this study, in parallel with the hypothermia, figure
prominently in protection against neuroinflammation. Pathologic activity of the complement/coagulation cascade
has been shown in patients suffering from a chronic form of ciguatera poisoning and is of particular interest in this
model. Anti-inflammatory processes were at work not only in the brain but were also seen in whole blood and
liver of these animals, creating a systemic anti-inflammatory environment to protect against the initial cellular
damage caused by the toxin.
Background
Ciguatoxins (CTXs) are a suite of heat stable, lipid solu-
ble, cyclic polyethers produced by benthic marine dino-
flagellates of the genus Gambierdiscus [1]. These toxins
activate voltage-gated sodium channels (VGSCs) [2], are
bioaccumulated and metabolized to increasingly potent
toxins through trophic transfer in reef associated fish
[3], and are responsible for causing ciguatera fish poi-
soning (CFP) in humans, affecting an estimated 50,000 -
100,000 people each year [4]. CFP is characterized by
acute gastrointestinal and neurological symptoms,
including vomiting, diarrhea, abdominal pain, severe
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any medium, provided the original work is properly cited.localized itching, tingling of extremities and lips, and
thermal dysthesia. While gastrointestinal symptoms typi-
cally resolve within few days, other symptoms of CFP
can last from several weeks to, in some cases, several
years [5]. These long term symptoms can include fati-
gue, weakness, depression, as well as hypersensitivity
to repeated exposure, and recurrence of symptoms
that may occur upon consumption of non-toxic fish or
alcohol [5].
Suites of CTX congeners have been distinguished,
with minor differences in their cyclic polyether back-
bone. As reviewed by Lewis [6], Pacific CTXs (P-CTX)
have thirteen fused rings, with either a seven (Type 1)
or eight (Type 2) member ring in the E position (Figure
1). CTX congeners are differentiated within each type
by the hydroxyl groups at their A- or M-ring, and exclu-
sively for the type-1, the four carbon saturated side
chain extending from the A-ring. Differences in the R-
groups of the type 1 P-CTX change the partition coeffi-
cient of the molecule by more than three orders of mag-
nitude (NCBI PubChem Compound log P value of 2.5
for P-CTX-1 and 5.7 for P-CTX-4B). P-CTX-4B, the
most lipophilic identified ciguatoxin, is a primary pro-
duct of the algae while P-CTX-1, more polar, is a fish
metabolite and 16-fold more potent than P-CTX-4B [7].
Other families of ciguatoxins have also been isolated
from the Caribbean and Indian Ocean [8,9]. The former
has fourteen fused rings; the later has not been structu-
rally elucidated. In the Pacific Ocean, neurological
symptoms dominate. Indian Ocean CFP is similar to the
Pacific with the addition of hallucinogenic symptoms
while gastrointestinal symptoms predominate in the
Caribbean [10]. P-CTX-1 is the most potent known
ciguatoxin and reported to cause human illness at 0.1
ppb [11]. It is a major congener found in carnivorous
fish of the region and is thought to be a significant
source of CFP in the Pacific [10].
The action of CTX isolated from a Gambierdicus toxi-
cus culture, from the Martinique clone MQ2, was pre-
viously investigated in mice [12,13]. The toxin induced a
rapid decrease in core body temperature that persisted
for several hours with a corresponding induction of c-
Fos mRNA in brain. Immunostaining for c-Fos-like
immunoreactivity, showed positive immunoreactivity in
only select brain regions including the medial preoptic
and supraoptic nuclei of the hypothalamus and certain
regions of the brain stem including the locus coeruleus,
dorsolateral parabranchial nucleus, area postrema and
A
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B
Figure 1 Backbones of Pacific and Caribbean ciguatoxins. A = P-CTX type 1, B = P-CTX type 2, C = C-CTX.
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that Caribbean ciguatoxin(s) produced by the algae had
neuroexcitatory actions on several autonomic hypothala-
mic and brain stem regions, many of which appeared to
be mediated by ascending projections.
Recent studies of acute CTX effects in mice have been
conducted with the more potent and polar P-CTX-1 to
examine toxicogenomics during a 24 hour period, which
coincides with observable symptoms. P-CTX-1 exposure
resulted in a rapid central response to lower body tem-
perature and reduced motor activity, and a more persis-
tent effect on spinal heat antinociception and delayed
fever-like response [14]. Gene expression studies were
conducted in parallel to characterize the immune
response by examining whole blood, as well as potential
detoxification pathways in the liver of these same ani-
mals. Through both proteomic and transcriptomic ana-
lysis of whole blood, there was evidence of an anti-
inflammatory Th2 immune response [15], which is
thought to be neuroprotective and may be advantageous
to preventing neuronal damage during exposure to
CTX. In the liver we identified differential expression of
several genes involved in phase 1 and phase 2 detoxifi-
cation pathways [16]. With such a high density of
sodium channels in the brain, even limited ciguatoxin
penetration makes this an interesting tissue to examine.
The current study was designed to investigate responses
of the brain to P-CTX-1 using oligonucleotide microar-
rays and real-time PCR. Gene ontology (GO) and Kyoto
Encyclopedia of Genes and Genomes (KEGG) molecular
pathway analysis were performed to identify possible
enrichment of genes with specific biological themes.
Results
Mouse Symptomatic Responses
T h ea n i m a l su s e di nt h i ss t u d yw e r ea l s oa n a l y z e di n
two companion papers looking at the transcriptomic
response to CTX in blood and liver, for further details
of symptoms see [15,16]. The treated mice all displayed
hallmark symptoms of CTX exposure including
hypothermia and hypoactivity while control animals dis-
played no obvious symptoms. All treated mice showed a
rapid depression in core body temperature, which
reached a minimum of 33°C at 1 h and slowly returned
to basal temperature (37°C) by 8 hr.
Microarray Analysis
Raw and processed gene expression data have been
deposited in NCBI’s Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo/, GEO Series accession
number GSE20949). Triplicate Agilent whole mouse
genome arrays from each time point (1, 4, and 24 h)
underwent weighted averaging by Rosetta Resolver soft-
ware to produce an average differential expression ratio
for every gene at each time point. As different cutoffs
for quality filtering for microarray data can provide dif-
ferent insights, we subjected our data to three different
levels of stringency filters: high (1.7 fold change, p < 10
-5
and signal > 70 counts in both channels); medium (1.7
fold change, p < 10
-5); and low (1.5 fold change, p <
0.0005) in at least one time point for a feature to be
called significant, and then analyzed each data set indi-
vidually. Of the 41,234 sequence probes on the array,
totals of 550, 707, and 1,625 (Additional file 1), respec-
tively, were found to be significantly differentially
expressed. Although there are cases on the array where
more than one probe is used to query different parts
along the sequence of a single gene, and in some
instances, identical probes to the same gene are repli-
cated mainly for QC purposes, the vast majority of
genes are queried using a single probe with the Agilent
platform. Similar to earlier transcriptional profiling in
blood and liver of the same CTX exposed animals, the
majority of differential expression was seen at the 4 hr
time point.
The use of different stringency filters, in this case,
produced data sets with similar results throughout the
analysis. For brevity, and more importantly a lack of
appreciable differences, we did not present each set indi-
vidually in all the figures and tables, but did present
results from each level of quality filter. Clustering of the
data resulting from each stringency filter was performed
by K-means using 2 different metrics, Euclidian and
Pearson, to identify genes with similar expression pat-
terns (Figure 2). Membership in a cluster can provide
insight into the activation of specific pathways, and
crosstalk between pathways. The use of two different
metrics for the K-means algorithm can identify different
patterns of similarity, which is helpful for interpreting
coordinated gene expression. The Pearson metric clus-
ters genes with an emphasis on profiles of similar shape
and direction while the Euclidian metric places an
emphasis on absolute distance between expression
values. Use of the different metrics produced slightly
different cluster membership, as illustrated for the med-
ium stringency filter data in Figure 2. This in turn pro-
duced slightly different ontology and pathway
enrichment results as well (Table 1).
Gene Ontology and Pathway Analysis
GO (gene ontology) analysis using DAVID (Database for
Annotation, Visualization of Integrated Discovery) [17]
can identify over representation of GO categories, which
can give insight into mechanisms responsive to cigua-
toxin. The resultant gene data from each stringency fil-
ter was used as a whole but tended to produce non-
specific, although signific a n t ,r e s u l t ss u c ha st h eG O
categories “metabolic process” and “binding”. Analysis of
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Overall, the described stringency and clustering metrics
differed only slightly in resultant GO enrichment.
Regardless of clustering metric or stringency, the genes
of the up-regulated cluster (Figure 2b &2h) showed no
significant enrichment for any GO category. The other
clusters (Figure 2d, f, g), however, were more revealing.
GO analysis of high, medium and low stringency filters,
for both Euclidean and Pearson metrics, were similar,
with only the medium stringency data shown (Table 1).
As a result of the different metrics, some genes fell into
different clusters producing different GO results, and no
significant results occurred for cluster 1C, using the
Pearson metric. When taken together, the most signifi-
cant ontology classifications were for acute inflamma-
tory response, response to external stimulus, and
response to wounding, regardless of clustering metric or
stringency filter.
KEGG pathway analysis of the 1,625 low stringency
genes showed significant enrichment (p < 0.05) for three
molecular pathways: complement/coagulation cascades,
linoleic acid metabolism and metabolism of xenobiotics
(Table 2). The last 2 pathways are dominated with cyto-
chrome p450 enzymes, or Cyps. Cyps are reductases
and oxidases critical to metabolism of xenobiotic com-
pounds such as drugs and the toxin used here. Many of
the Cyp isoforms found in brain in this study are also
found in liver and are discussed in detail in the compa-
nion paper Morey et al, describing gene expression in
the liver of these animals, the major site for metabolism
of xenobiotics [16]. DAVID analysis of medium and
high stringency data revealed enrichment of 5 pathways,
including the 3 resulting from the low stringency set, as
well as two new ones, arachidonic acid metabolism and
g hexachlorocyclohexane degradation, both Cyp rich.
Analysis of individual clusters strengthened the signifi-
cance (lower p-values) of these pathways, but did not
add any new insights.
The enriched molecular pathways and GO categories
identified at all stringency levels for this data were pre-
dominantly driven by genes in the cluster down-regu-
lated at 4 hrs and strongly up-regulated at 24 hrs
(Figure 2d and 2f). The dramatic fold change seen here
could be due in part to low expression levels for most
of these genes, such that small changes in fluorescence
intensity result in large fold-changes that may overesti-
mate their responses. This is the main reason we
added a minimum intensity criterion to our most strin-
gent filter, minimizing false positives. In addition to
genes involved in complement and coagulation path-
ways, and cytochrome p450 genes, there are several
genes of the mouse major urinary protein family, or
Mup, found in this down-regulated cluster. Mups are
small ligand binding proteins best known for their role
in excretion of pheromones. The differential expression
of these genes is probably a result of chemosignalling
induced by the stress of the experiment, with a relative
lag in induction created by the hypothermia of treated
animals. The binding pocket of Mups will accommo-
date a variety of small hydrophobic pheromone ligands,
typically one quarter the size of ciguatoxin [18], but it
would be interesting to determine if these proteins
m a yb ea b l et ob i n da n de x c r e t eh y d r o p h o b i c
ciguatoxins.
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Figure 2 Kmeans clustering of medium stringency microarray
dataset. 2a-d Pearson metric, 2e-h Euclidean metric. Each color
represents the results of a discrete K-means cluster. Each line in the
cluster represents the expression of a member gene over the time
course. Bar across figures b-d and f-h indicates no change from
control animal gene expression.
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For each tissue, the low stringency conditions, (1.5 fold
change, p < 0.0005) were used to filter for significant
gene probes. This resulted in 17 probes that were
differentially regulated and common to all tissues (Table
3). There were two instances of different, but similarly
reporting, probes for the genes FK506 bp and Gag pro-
tein, reducing our unique gene total to 15. In general,
Table 1 Comparison of Gene Ontology and metabolic pathway enrichment by cluster metric (Euclidean vs Pearson) for
medium stringency dataset.
Pearson metric - Cluster 1 d - Biological Process Genes % input P-Value Benjam
response to wounding 28 10.6 1.7E-15 9.2E-12
acute inflammatory response 17 6.4 2.6E-15 6.9E-12
response to external stimulus 32 12.1 5.6E-14 9.6E-11
inflammatory response 20 7.6 4.3E-11 5.6E-08
acute-phase response 9 3.4 7.8E-10 8.1E-07
response to stress 31 11.7 1.0E-07 9.0E-05
electron transport 22 8.3 2.4E-07 1.7E-04
complement activation 8 3 9.5E-07 6.2E-04
activ of plasma proteins in acute inflam response 8 3 9.5E-07 6.2E-04
complement activation, classical pathway 7 2.7 1.2E-06 6.0E-04
wound healing 10 3.8 1.8E-06 8.5E-04
generation of precursor metabolites and energy 23 8.7 2.3E-06 1.0E-03
humoral immune response by immunoglobulin 7 2.7 3.7E-06 1.5E-03
complement activation, alternative pathway 5 1.9 4.3E-06 1.6E-03
blood coagulation 8 3 8.1E-06 2.8E-03
coagulation 8 3 9.1E-06 2.9E-03
defense response 25 9.5 9.1E-06 2.8E-03
hemostasis 8 3 1.1E-05 3.2E-03
regulation of body fluid levels 8 3 5.0E-05 1.4E-02
activation of immune response 8 3 7.4E-05 1.9E-02
regulation of multicellular organismal process 14 5.3 1.1E-04 2.7E-02
regulation of immune response 9 3.4 1.4E-04 3.3E-02
immune response 19 7.2 1.5E-04 3.4E-02
regulation of immune system process 9 3.4 1.6E-04 3.3E-02
positive reg of multicellular organismal process 9 3.4 2.2E-04 4.4E-02
innate immune response 8 3 2.2E-04 4.4E-02
Euclidian metric - Cluster 1g - Biological Process Genes % input P-Value Benjam
acute inflammatory response 8 3.8 1.5E-05 7.5E-02
humoral immune response by immunoglobulin 6 2.8 2.1E-05 5.3E-02
response to external stimulus 17 8.1 2.7E-05 4.6E-02
Euclidian metric - Cluster 1f - Biological Process
response to wounding 16 24.6 3.4E-14 1.7E-10
response to external stimulus 17 26.2 1.4E-12 3.6E-09
acute inflammatory response 9 13.8 1.8E-10 3.1E-07
acute-phase response 7 10.8 2.2E-10 2.9E-07
response to stress 17 26.2 3.4E-09 3.5E-06
wound healing 8 12.3 1.6E-08 1.4E-05
inflammatory response 10 15.4 3.6E-08 2.7E-05
blood coagulation 6 9.2 1.3E-06 8.5E-04
coagulation 6 9.2 1.4E-06 8.2E-04
hemostasis 6 9.2 1.7E-06 8.7E-04
regulation of body fluid levels 6 9.2 5.2E-06 2.4E-03
defense response 11 16.9 8.4E-05 3.6E-02
Genes heading indicates number of genes mapped to an ontology category. % input indicates the percentage of mapped genes from the total number of genes
in the cluster. P-Value derived from Fishers exact test and Benjam indicates P-value after application of Benjamini multiple test correction.
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three tissues assayed at 1 and 4 hrs. However, at 24 hrs,
there was no statistically significant differential expres-
sion for these 15 genes in brain, only 2 significant chan-
gers in liver, and 1 in blood. When two of the three
tissues had statistically significant differential gene
expression at any time point, all three tissues were con-
sistently regulated in the same direction as shown in
Table 3, with two exceptions. C/EBP was significant at
both 1 and 4 hours in all three tissues, although in
brain and liver the gene was up-regulated at both time
points, while in blood it was down-regulated at both
time points. Arginase1 was significantly up-regulated in
blood and liver but down in brain at 4 hrs.
qPCR Validation
Twenty-two genes were selected for verification by real-
time PCR, including transmembrane protein 59 used for
normalization (Figure 3). Overall, the changes in gene
expression measured by qPCR strongly supported the
Table 2 Comparison of KEGG molecular pathway enrichment for high, medium and low stringency filtered genes.
Low Stringency Set Genes %input P-Value Benjam
Complement and coagulation cascades 26 1.3 1.3E-08 2.6E-06
Linoleic acid metabolism 15 0.7 1.3E-04 1.3E-02
Metabolism of xenobiotics by cytochrome P450 18 0.9 5.9E-04 3.8E-02
Medium Stringency Set Genes %input P-Value Benjam
Complement and coagulation cascades 19 3.1 7.4E-12 1.5E-09
Linoleic acid metabolism 15 2.5 1.1E-10 1.1E-08
Metabolism of xenobiotics by cytochrome P450 16 2.6 5.9E-09 3.8E-07
Arachidonic acid metabolism 10 1.7 6.2E-04 3.0E-02
gamma-Hexachlorocyclohexane degradation 6 1 9.1E-04 3.5E-02
High Stingency Set Genes %input P-Value Benjam
Linoleic acid metabolism 15 2.9 1.2E-11 2.3E-09
Complement and coagulation cascades 16 3.1 7.3E-10 7.1E-08
Metabolism of xenobiotics by cytochrome P450 15 2.9 6.0E-09 3.9E-07
Arachidonic acid metabolism 10 2 1.8E-04 8.9E-03
gamma-Hexachlorocyclohexane degradation 6 1.2 4.3E-04 1.7E-02
Genes heading indicates number of genes mapped to an ontology category. % input indicates the percentage of mapped genes from the total number of genes
in the cluster. P-Value derived from Fishers exact test and Benjam indicates P-value after application of Benjamini multiple test correction.
Table 3 Significantly altered genes common to brain, liver and blood.
Accession # Sequence Description 1 hr 4 hr
NM_019440 Immunity-related GTPase family M member 2 (Irgm2) ↑
NM_029000 GTPase, very large interferon inducible 1 (Gvin1) ↓
AF053745 Glycosylated gag protein (Mus dunni endogenous virus) ↑
NM_007705 Cold inducible RNA binding protein (Cirbp) ↑
NM_008245 Hematopoietically expressed homeobox (Hhex) ↓
NM_026268 Dual specificity phosphatase 6 (Dusp6) ↓
NM_008361 Interleukin 1 beta (Il1b) ↓
NM_010220 FK506 binding protein 5 (Fkbp5) ↑↑
BC057864 Polymeric immunoglobulin receptor 3 precursor (Pigr3) ↑↑
NM_008330 Interferon gamma inducible protein ↓
NM_007679 CCAAT/enhancer binding protein (C/EBP), delta
NM_010907 NFkB inhibitor, alpha (Nfkbia) ↑↑
NM_016693 Mitogen-activated protein kinase kinase kinase 6 (Map3k6) ↑
BC021340 Poly (ADP-ribose) polymerase family, member 14 (Parp 14) ↓
NM_007482 Arginase 1 (Arg1)
Arrows indicate where gene expression was in the same direction for all three tissues, when at least 2 tissues reported statistically significant data. Blank cells
were largely due to the lack of significant data from more than 1 tissue at that particular time point.
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Page 7 of 14microarray results, with a correlation of 0.90 across the
time series (Spearman’s Rho, p < 0.0001, n = 66). Corre-
lations at individual time points decreased throughout
the time series with a maximum correlation of 0.91
(Spearman’s Rho, p < 0.0001, n = 22) observed at 1 hr.
Correlations decreased to 0.89 (Spearman’sR h o ,p<
0.0001, n = 22) or 0.65 (Spearman’sR h o ,p=0 . 0 0 1 1 ,n
= 22) at the 4 and 24 hr time points, respectively. The
fact that many of the genes validated exhibited very
minor changes at the 24 hr time point is likely the
cause of decreased correlation, as has been previously
observed [19]. Overall, the direction of change reported
by qPCR and microarray agreed for 59 of 66 samples
and, with one exception, the observed fold change was
less than 1.2 when the methods disagreed.
Discussion
This study examines the genomic response in brain to a
sub-lethal dose of the potent marine neurotoxin, P-
CTX-1. The neurotoxic action of CTX is attributed to
its activation of voltage-gated sodium channels (VGSCs)
in peripheral and central nervous systems and cardiac,
smooth and striated muscle, which collectively impact
multiple organ systems [20]. Ciguatoxin is also asso-
ciated with action on other systems, such as immune
cells [21], not traditionally viewed as excitable. The
brain provides a fascinating organ for investigation of
ciguatoxin action because of its regional specialization,
universal expression of voltage-gated sodium channels
on neurons and certain glial cells, direct and humoral
input from the periphery and a specialized immune sys-
tem. Yet, other aspects of the brain provide complica-
tions to such analysis, such as regional differences in
permeability to toxic agents and a strong hypothermic
response to ciguatoxin in mice that is rarely reported in
humans.
Hypothermia/Immediate Early Response Genes/
Neuroprotection
CTX-treated mice displayed a rapid 4°C decrease in core
body temperature, which reached a minimum at 1 hr
a n ds l o w l yr e t u r n e dt ob a s e l i n eb y8h r .O t h e rm a r i n e
polyether toxins, including maitotoxin and brevetoxin,
cause similar acute stage hypothermia in mice [22,23] as
do a variety of other xenobiotics including heavy metals,
ethanol and organophosphates [24]. Many studies have
shown hypothermia to positively impact recovery from
traumatic injury and this hypothermic response appears
to be a programmed protective mechanism against toxic
insult. A recent review of beneficial effects of induced
hypothermia after neurological injury cited four key ele-
ments for success: 1) speed of induction, with better
outcomes in animals when cooling commences shortly
after injury, 2) duration of cooling, which depends on
degree of injury, 3) speed of rewarming, which should
be slow, otherwise destructive processes will be reini-
tiated, and 4) management of side effects [25]. Animals
in this study showed a rapid induction of hypothermia,
with maximal cooling one hour after toxin exposure.
Their return to normothermia took 7 hrs, relatively pro-
tracted compared to initiation. The protective mechan-
isms of hypothermia after brain trauma are well
documented and include suppression of excitotoxicity,
free radical production, intercellular signaling cascades,
cerebral metabolism, neuroinflammation, blood brain
barrier disruption, and seizure activity, as well as stabi-
lizing membranes and cytoskeletal elements, in addition
to modification of early gene expression [26].
Immediate early genes (IEGs) are a class of genes that
quickly respond to a wide range of stimuli and also reg-
ulate a wide variety of functions. Primarily transcription
factors, these genes such as Fos, Jun and Early Growth
Response (EGR) isoforms can be found active in most
acute gene expression studies. One study of hypother-
mia in rats proved to dramatically reduce the expression
of IEGs after brain injury, but only to the level of con-
trol animals [27]. What is interesting in this study is
that these genes, in particular, c-Fos, Jun B, Immediate
early response 2 (Ier2), nuclear receptor 4A (Nr4a1),
transcription factor NXF (NXF), Early growth response
1 (EGR1), EGR2, EGR4 are all significantly down-regu-
l a t e da t1a n d4h r sc o m p a r e dt oc o n t r o l s .M a n yo f
these genes were independently validated by RT-PCR
with similar results (Figure 3). In contrast, an earlier
investigation of a Caribbean CTX isolated from algae,
indicated a transient induction of c-Fos mRNA by
northern analysis that paralleled a reduction of core
body temperature [12]. In that study, immunohisto-
chemistry for the Fos protein showed limited regional
expression in hypothalamic and brain stem nuclei. It is
possible that the Caribbean CTX used previously is less
polar than P-CTX-1 used in the current study, where
cFos is down-regulated, and therefore may have greater
brain penetration. Comparable studies with the marine
algal toxin domoic acid, a glutamate analog not known
to cause hypothermia, produced acute up-regulation of
these genes in the brain [28] and extensive expression of
Fos and neuroexcitatory damage throughout the limbic
system [28-31]. Domoic acid induced responses of
immediate early genes parallel their rapid induction in
brains of animals following hypoxia-ischemia, and are
thought to play a role in the death cascade of sensitive
neurons [32]. Another study using microarrays in a
mouse seizure model found 6 genes specific to seizure
that were up-regulated after one hour [33]. Three of
these genes are significantly down-regulated in response
t oP - C T Xa t1a n d4h o u r s ,c F o s ,E g r 1a n dN x f .A
fourth, serum and glucocorticoid regulated kinase (Sgk)
Ryan et al. BMC Neuroscience 2010, 11:107
http://www.biomedcentral.com/1471-2202/11/107
Page 8 of 14is up-regulated at 1 and 4 hrs while the remaining two
were statistically unchanged in this study. Significantly,
glucocorticoids up-regulate anti-inflammatory gene
expression while also suppressing inflammatory gene
expression [34]. Glucocorticoid regulation of inflamma-
tion is ubiquitous and is reflected by a gene found sig-
nificantly up-regulated at 1 and 4 hrs in all tissue
studied from these animals, FK506 binding protein 5.
Fk506bp5 has been shown to inhibit binding of cortisol
to the glucocorticoid receptor [35] and its increased
expression suggests tight regulation of glucocorticoid
signaling in the anti-inflammatory response of these ani-
mals. Additionally, CTX has been shown to act directly
on adrenal chomafin cells and increase the release of
catecholamines [36,37].
Another hallmark of anti-inflammatory response in
the CTX treated mice is the down-regulation of IL1b
gene expression in brain at 4 h (-1.7 fold), as was also
seen in liver (-5.9 fold) and blood (-2.9 fold) [15,16].
IL1b is well known for its role in inflammation and the
generation of fever, its down regulation, along with the
down regulation of other inflammatory cytokines, may
be contributing to the hypothermic response [38]. To
further diminish IL1b signaling, the IL1 type 2 receptor
is up-regulated, which is a decoy receptor that binds
IL1b without any concomitant signaling, thereby seques-
tering the inflammatory cytokine [39]. This same regula-
tion of Il1b was also seen in blood of these animals.
Chemokine ligand 5, Ccl5, a chemotactic signal for eosi-
nophil and T lymphocyte recruitment into inflamed
areas was also down-regulated here. Another protein
indicative of inflammation is the s100 protein heterodi-
mer A8 and A9, calgranulin. Both subunits were found
significantly down-regulated at 24 hrs. Additionally, just
missing our fold change cut-off, cyclooxygenase II
(COX2) was also down-regulated (-1.4 fold, p = .00004)
in brain at 4 hrs. Hypothermia is quite effective at sup-
pressing inflammation, and inflammatory genes that are
down-regulated seem to correlate well with the tem-
perature suppression seen here. Concurrently, many
anti-inflammatory genes, such as those involved with
glucocorticoid signaling, are up-regulated acutely.
Coagulation and Complement
Molecular pathway analysis identified significant activity
of complement and coagulation cascades. The comple-
ment system is a critical first line of defense against
invading pathogens and also in the removal of cellular
debris, such as necrotic tissue. The coagulation system
is critical in maintaining hemostasis and together these
two systems control many of the initial events in
response to injury. Both systems employ cascades of ser-
ine proteases, which now have been shown to exhibit
crosstalk at multiple levels, and together these systems
significantly influence the magnitude and progression of
inflammation in response to injury [40]. At all levels of
data stringency, these pathways were found to undergo
a high degree of regulation compared to control ani-
mals. Additionally, two poorly annotated genes in the
high stringency data set, that were not mapped to the
KEGG pathway (Figure 4), appear to have von Willeb-
rand factor domains, a protein crucial to blood coagula-
tion. The complement/coagulation pathway is of
particular interest in light of recent findings in cases of
chronic ciguatera illness in humans. These patients suf-
fer from pathologic expression of activated complement
component C4 as well as the essential clotting protein
Factor VIII, ristocetin associated cofactor and von Will-
ebrand’s antigen itself [41]. The expression of these
pathways is sharply down-regulated after acute CTX
exposure in mice and coincides with the temperature
suppression, which may be prophylactic against a poten-
tially pronounced dysregulation.
Hypo-osmotic stress, due to sodium influx caused by
ciguatoxin, is thought to cause neuronal swelling, which
is why the osmolyte mannitol is thought to reduce some
symptoms of exposure [42,43]. NFAT5, a transcription
factor found to be up-regulated in response to hyper-
osmotic stress [44] was down-regulated at 1 hr. Interest-
ingly, recent studies have extended the direct actions of
ciguatoxins beyond neurons and into blood cells. A
study using frog erythrocytes showed that ciguatoxin
caused swelling and actin cytoskeletal deformation in
RBCs, through nitric oxide pathways [45]. The enzyme
arginase 1 (Arg1) was one of only fifteen genes that was
significantly regulated in liver, blood and brain of the P-
CTX treated mice. Arg1 competes with inducible nitric
oxide synthase (iNOS) for the L-arginine substrate,
causing the reciprocal inhibition of these enzymes [46].
Expression of Arg1 is induced in macrophages predomi-
nantly by anti-inflammatory Th2 cytokines while iNOS
is induced by inflammatory Th1 cytokines [47]. An in
vitro study in macrophages showed ciguatoxin to stimu-
late an immune response, including a dramatic induc-
tion of iNOS [48]. Although Arg1 was sharply up-
regulated in blood of the CTX treated mice, it was
down-regulated in brain at 4 hrs.
Comparison of Brain Gene Expression with Other Tissues
Fifteen genes were found to be similarly, and signifi-
cantly, altered by ciguatoxin exposure in brain, liver and
blood (Table 3). An interesting aspect of this compari-
son is the diversity of function between these tissues
and the deficiency of target voltage gated sodium chan-
nels (VGSCs) in liver and leukocytes. The regulation of
these genes is more likely driven by hypothermia and
humoral input, rather than direct action of the toxin. In
fact, many shared genes are readily identified as being
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inducible RNA binding protein (Cirbp) was up-regu-
lated, peaking at 4 hrs in liver and brain, and then peak-
ing in blood at 24 hrs. The differential expression of this
gene is easily explained by the temperature suppression.
Cirbp is a cold stress inducible protein that has been
shown to protect cells from TNFa induced apoptosis
[49]. Another sign of stress response in these animals is
the common up regulation of the endogenous retroviral
protein Gag. Gag can initiate innate immune activity
through toll like receptors; TLR7, a receptor important
to innate viral response, was found in the high strin-
gency data, up-regulated more than 2-fold in brain.
However, with the down regulation of genes involved
with inflammation, the acute effects of TLR signaling
are probably not fully realized in these animals.
Conclusions
Although some of the genes in the brain induced by P-
CTX-1 could indicate neuronal damage and dysfunction,
these genes were not statistically over-represented,
unlike the pathways discussed here. This is consistent
with sensory, motor and autonomic actions of cigua-
toxin that originate in the periphery. Instead, what was
most apparent from this data was the suppression of
inflammatory processes and activated humoral signaling.
The hypothermic response coupled with down-regula-
tion of complement/coagulation pathways and other
inflammatory pathways could be involved in suppression
of cerebral inflammation and edema during a critical
time window after trauma. These processes were at
work not only in the brain but were common to blood,
liver and brain, creating a systemic anti-inflammatory
environment to protect against the initial cellular
damage caused by the toxin. Hypothermia is not a typi-
cal feature of human intoxications, but reports of tem-
perature dysregulation are not unusual in ciguatera
poisoning. Future work is needed to address questions
raised in this study regarding potential differences in
brain penetration and activation of thermoregulatory
neurons by the different toxin congeners, as well as
humoral contributions to temperature management.
Methods
Exposure to P-CTX-1
All exposures were conducted at Duke University in
accordance with institutional and NIH guidelines for the
ethical care and use of laboratory animals. Adult male
C57/BL6 mice were maintained on a 12 hr:12 hr light:
dark cycle and were given food and water ad libitum.
Radio frequency transmitters were implanted in the
mice to measure core temperature and motor activity as
previously published [50]. Briefly, mice were anesthe-
tized with ketamine HCl and a sedative analgesic, mede-
tomidine HCl, and the transmitter (TA10TA-F40; Data
Science International Sciences, St. Paul, MN) was
implanted in the abdominal cavity. Following surgery,
mice were administered atipamezol HCl by i.p. injection
to counteract the anesthetic effect of ketamine. The
mice were allowed at least 10 days of recovery before
testing while animal health was monitored.
On the day of exposure, mice were weighed and ran-
domly assigned to control or experimental groups.
Three groups of control mice (n = 3) were injected i.p.
with a single dose of physiological saline with 1% Tween
60 (vehicle). Three groups of experimental mice (n = 3)
were injected ip with 0.26 ng/g P-CTX-1 in vehicle. P-
CTX-1, obtained from Dr. Richard Lewis (University of
Queensland, Australia), was purified from moray eel
liver as described in Lewis et al. [51] with >90% purity.
At 1, 4, and 24 hr post-injection, 3 experimental mice
and 3 time-matched controls were anesthetized with 50
mg/ml sodium pentobarbital i.p. Brains were immedi-
ately dissected, flash frozen in liquid nitrogen, and
stored at -80°C until RNA processing.
RNA processing
The brains of the 3 control mice for each time point
were pooled prior to RNA extraction while RNA was
extracted from brains of individual CTX exposed mice.
The brains were crushed using a BioPulverizer (BioSpec
Products, Inc., Bartlesville, OK) in liquid nitrogen. The
crushed tissue was immediately placed in cooled Tri-
Reagent (Molecular Research Center, Inc., Cincinnati,
OH) and homogenized using a Tissue-Tearor (United
Lab Plastics, St. Louis, MO) at 25,000 rpm for 1 min on
ice. All homogenates were processed according to the
manufacturer’s protocol. RNA was resuspended in
nuclease-free water and further processed using an
RNeasy mini-column (Qiagen, Valencia, CA) according
to manufacturer’s protocol. RNA was then quantified
using a NanoDrop ND-1000 (Wilmington, DE) and qua-
lified on an Agilent 2100 Bioanalyzer (Foster City, CA).
RNA Labeling and Array Hybridization
Five hundred nanograms of total RNA from control and
experimental animals was separately amplified and
labeled with either Cy3 or Cy5 labeled CTP (GE Health-
care Life Sciences) using the Ambion Message Amp
Amino Allyl kit according to manufacturer’sp r o t o c o l .
Following labeling and clean up, amplified RNA and dye
incorporation were quantified using a NanoDrop ND-
1000. Seven hundred fifty ng each of Cy3 and Cy5
labeled targets were combined and hybridized to an Agi-
lent catalog 44 K whole genome mouse oligonucleotide
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washed consecutively in solutions of 6X SSPE with
0.005% N-lauroylsarcosine and 0.06X SSPE with 0.005%
N-lauroylsarcosine for 1 min each at room temperature.
This was followed by a final 30 sec wash in Agilent Sta-
bilization and Drying solution. Three biological repli-
cates, including a dye swap, were performed at each
time point.
Microarray Analysis
The microarrays were run in a two color format where at
each time point total brain RNA from 3 individual mice
exposed to P-CTX-1 was compared to pooled total brain
RNA from time-matched control mice (n = 3). Microar-
rays were imaged on an Agilent microarray scanner,
extracted with Agilent Feature Extraction software version
A8.5.3, and data analyzed with Rosetta Resolver 7.0 gene
expression analysis system (Rosetta Informatics, Seattle,
WA). Features were subjected to a combination linear and
LOWESS normalization algorithm using a rank consis-
tency filter. Resolver generated a weighted average compo-
site array from the replicates (n = 3) for each time point
based on the error model for the Agilent platform [52].
The composite arrays were used for a trend analysis to
determine the expression pattern of genes throughout the
time course. The data were subjected to three levels of
stringency filters, high, medium and low, to sort out possi-
ble bias due to data quality. These filters consisted of: high
(1.7 fold change) + (p < 10
-5) + (signal > 70 counts in both
channels); medium (1.7 fold change) + (p < 10
-5); and low
(1.5 fold change) + (p < 0.0005) in at least one time point.
Data resulting from all 3 stringency filters were clustered
using K-means with both Euclidean and Pearson metrics
and further analyzed using the web tool DAVID (Database
for Annotation, Visualization and Integrated Discovery)
[17]. Gene ontology (GO) and KEGG molecular pathway
analysis was performed to identify possible enrichment of
genes with specific biological themes using both the data
set as a whole and then in the individual K-means clusters.
DAVID calculates a modified Fishers Exact p-value to
demonstrate GO or molecular pathway enrichment, where
p-values less than 0.05 after Benjamini multiple test cor-
rection are considered to be strongly enriched in the anno-
tation category. For comparison between tissues, our low
stringency filter (fc > 1.5, p < .0005) was applied to data
from brain, liver and blood, to capture maximum overlap
for analysis.
Quantitative Real-Time PCR
Differentially expressed genes of interest were selected
for validation of the microarray results by quantitative
real-time PCR (qPCR). Triplicate reverse transcription
reactions were carried out using 500 ng total RNA
with an oligo(dT) primer using Ambion’sR E T R O s c r i p t
Kit (Austin, TX). Gene specific primers (Additional file
2) were used for qPCR on an ABI 7500 using the ABI
Power SYBR Green master mix (Applied Biosystems,
Foster City, CA). The optimal annealing temperature
f o re a c hp r i m e rs e tw a sd e t e r mined prior to the analy-
sis of experimental samples. The specificity of each
primer set and size of the amplicon were verified by
analysis with Agilent’s Bioanalyzer 2100 and further
confirmed by melting curve analysis. The efficiency of
each primer set was determined using a serial dilution
series of cDNA from mouse brain. Duplicate 25 μl
qPCR reactions were run from each cDNA triplicate.
A cycle threshold (Ct) was assigned at the beginning of
the logarithmic phase of PCR amplification and the
difference in the Ct values of the control and experi-
mental samples were used to determine the relative
expression of the gene in each sample. Transmem-
brane protein 59 (NM_029565) was used for normali-
zation as its expression did not change significantly in
microarray or qPCR experiments (Wilcoxon, p > 0.05).
As data were not normally distributed (Shapiro-Wilk
W test), correlation to the microarray data set was
determined by Spearman’s Rho using JMP version
5.1.2 (SAS Institute, Cary, NC). Gene abbreviations;
basic helix-loop-helix/Per-ARNT-Sim (bHLH-Pas),
Cold inducible RNA-binding protein (Cirbp), Chemo-
kine (C-X-C motif) ligand 7 (Cxcl7), Early growth
response 1 (Egr1), Early growth response 4 (Egr4), c-
fos (Fos), Haptoglobin (Hp), Immediate early response
2 (Ier2), Interleukin 1 beta (Il1b), Interferon inducible
protein 47 (Infi47), Jun-b (JunB), MAP kinase kinase
kinase 6 (Map3k6), Nuclear Factor kappa B (NF-Kap-
paB), Placenta specific 8 (Plac8), RNA binding motif
protein 3 (Rbm3), s100a8 (s100a8), s100a9 (s100a9),
Serum and glucocorticoid regulated kinase (Sgk),
Serum and glucocorticoid regulated kinase 3 (Sgk3), T-
cell specific GTPase (Tgtp).
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Additional file 1: Processed and filtered microarray data. The
processed and filtered gene expression data used for analysis.
Additional file 2: PCR primers. Accession numbers for genes along
with PCR primers and annealing temperatures used for RT-PCR validation
of microarray data.
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